When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Watch our Dolphins Deep Dive live stream as the South Florida Sun Sentinel’s Chris Perkins and David Furones discussed Quinn Ewers’ future and weighed in on if Mike McDaniel should return. On ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

Compromise is key to keeping a team humming along. Say one person wants an inrunner electric motor, and the other prefers outrunner. What to do? Well, if you work at [Deep Drive], the compromise ...

In the world of tough, reliable timepieces built for guys who push limits—whether that's exploring underwater caves or just appreciating gear that can handle anything—Zenith has stepped up its game.

In May 2025, Google officially introduced Material 3 Expressive, the next evolution of Android’s design language, arriving after the launch of Android 16. This sweeping UI update is a significant step ...

We were impressed when we first drove the 2026 Mercedes-Benz CLA. The electric subcompact sedan punches above its weight, riding on a new platform with 800-volt architecture and boasting a new ...